A Pilot Study Assessing Efficacy, Safety, and Tolerability of EmSam [selegiline] in Bipolar Depression.

Trial Profile

A Pilot Study Assessing Efficacy, Safety, and Tolerability of EmSam [selegiline] in Bipolar Depression.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 14 May 2013

At a glance

  • Drugs Selegiline (Primary)
  • Indications Bipolar I disorders; Bipolar II disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2008 Status changed from recruiting to suspended due to "current lack of medication support".
    • 05 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top